ARCHIVES

Phase II Study Shows Positive Results in Reducing Dry Mouth

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Expiring Program Offer Flexibility

February 12, 1982

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001